These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6808385)

  • 1. [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].
    Tilsner V; Reuter H
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):553-7. PubMed ID: 6808385
    [No Abstract]   [Full Text] [Related]  

  • 2. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
    Hay CR; Lozier JN; Lee CA; Lafan M; Tradati H; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant factor VIII in hemophilia.
    Cohen A; Butler R
    N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of porcine factor VIII in Japan.
    Yoshioka A; Shima M; Morichika S; Terada S; Fukui H
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):26-8. PubMed ID: 7939769
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemophilia treatment. Side effects during immune tolerance induction.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors, what is the risk of treatment intensity?
    Collins PW
    J Thromb Haemost; 2007 Jul; 5(7):1380-2. PubMed ID: 17445122
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical study of congenital factor XIII deficiency (author's transl)].
    Nakamura K; Itakura T; Yoshioka T; Suou T; Imai A
    Rinsho Ketsueki; 1977 May; 18(5):636-47. PubMed ID: 904084
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 13. Side effects of substitution therapy--Newcastle 1976.
    Scand J Haematol Suppl; 1980; 35():55-64. PubMed ID: 6247760
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience concerning substitution therapy of adult haemophiliacs in the Grisons (author's transl)].
    Hartmann S
    Ther Umsch; 1979 Apr; 36(4):301-6. PubMed ID: 451948
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylaxis in hemophilia].
    Ortega F; Martin-Villar J; Navarro JL
    Sangre (Barc); 1970; 15(3):355-61. PubMed ID: 5486763
    [No Abstract]   [Full Text] [Related]  

  • 16. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor VIII inhibitor in a patient with mild haemophilia A (author's transl)].
    Gastaldi G; Avanzi G; Saccon C; Galletti A
    Haematologica; 1975 Dec; 60(4):477-84. PubMed ID: 816717
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A; Roisenberg I
    Thromb Haemost; 1999 Mar; 81(3):475-6. PubMed ID: 10102489
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)].
    Fukutake K; Fujimari M; Ukita M; Kitahara T
    Rinsho Ketsueki; 1973 Dec; 14(0):1393-99. PubMed ID: 4807613
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.